Company: PolyPid Ltd.
Ticker: Nasdaq: PYPD
Sector: Healthcare
Investor Contact: Ben Shamsian

PolyPid News

News

PolyPid Ltd. Announces Pricing of Initial Public Offering

PETAH TIKVA, Israel, June 26, 2020 -- PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage pharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary PLEX technology, announced the pricing of...

Skip to content